YKL-40 in hemodialyzed patients with and without cardiovascular complications – The enhancement by the coexistence of the seropositivity against hepatitis C virus infection

This publication has 28 references indexed in Scilit:

• YKL‐40 in type 2 diabetic patients with different levels of albuminuria
  European Journal of Clinical Investigation, 2010
• Increased YKL-40 expression in patients with carotid atherosclerosis
  Atherosclerosis, 2010
• Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
  Gut, 2010
• YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria
  Diabetes Care, 2009
• Prediction of coronary atherosclerotic disease with liver transaminase level
  Liver International, 2007
• Association between Neopterin and Carotid Intima-Media Thickness in Hemodialysis Patients
  Nephron Clinical Practice, 2005
• Noninvasive monitoring of patients with chronic hepatitis C
  Hepatology, 2002
• Inflammation and Atherosclerosis
  Circulation, 2002
• Serum neopterin concentrations in chronic liver disease.
  Gut, 1995
• Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.
  Journal of Experimental Medicine, 1984